If you have been suffering from arthritis for a while, you have likely tried numerous treatments, such as anti-inflammatory medications, joint injections, physical therapy, and more. Some people find some relief. Many people do not or do for a while until they don’t again. When you see something like red light therapy in your search and on arthritis forums, it is reasonable that you want the truth, not the hype.
Here’s what the research actually reveals – broken down by type of arthritis, some context on where it’s solid, where it’s still emerging, and what you’d need to do to have it get a fair chance.
What Arthritis Is Doing to Your Joints
Arthritis isn’t one disease. It is a group of over 100 conditions but most people will hear two: osteoarthritis (OA) and rheumatoid arthritis (RA). On the surface, they are alike, painful, stiff, swollen joints, but the underlying biology is quite different and that’s what matters when you’re considering if any kind of treatment makes sense.
With OA, the cartilage that protects the joints wears down over time. It’s mostly mechanical and degenerative and is caused by previous injuries, weight, genetics and age. The inflammation in OA is real, but is a secondary response to the damage, not caused by the damage.
Rheumatoid arthritis is an autoimmune disease. Your body’s immune system attacks the lining of your joints, causing inflammation that can damage surrounding tissue, cartilage and bone over time. It typically affects several joints at the same time, on both sides of the body, and is often accompanied by systemic symptoms – such as fatigue, fever, and sometimes heart and lung.
Why does this distinction matter for red light therapy? The mechanisms of light interaction with tissue are vastly different from those of RA vs. OA and the evidence shows it is different.
How Red Light Therapy Works at the Joint Level
Photobiomodulation (PBM) or red light therapy is a therapy based on the application of specific wavelengths of red and near-infrared light to elicit biological responses in cells. The main target is an enzyme known as cytochrome c oxidase that is centrally important in cellular energy production.
This enzyme activates the mitochondria to generate more adenosine triphosphate (ATP) – cells’ energy currency – when illuminated by the correct wavelength of light. The more ATP, the more quickly the cells can repair themselves, manage inflammation and fight oxidative stress.
For arthritic joints specifically, the mechanisms being studied include:
Cytokine modulation – PBM has been demonstrated to inhibit pro-inflammatory cytokines such as tumor necrosis factor alpha (TNF-α), interleukin 1 (IL-1) and interleukin 6 (IL-6), all of which play a role in causing joint inflammation in both OA and RA. This effect was described in a comprehensive review in 2023 in International Journal of Molecular Sciences.
Cartilage protection – Light exposure seems to decrease the activity of enzymes that break down collagen and cartilage called matrix metalloproteinases (MMPs). Maintaining the structural tissue is very important for long-term joint health.
Nitric oxide release – By using near-infrared light, nitric oxide is released from the cells, which dilates the vessels in the local tissue and thus increases the blood circulation. An improvement in blood flow will improve the supply of oxygen and nutrients to damaged tissue and increase the removal of inflammatory waste products.
Nerve modulation – There have been some studies that propose that PBM may also help decrease the transmission of pain signals at the nerve level, apart from its anti-inflammatory activity.
Photobiomodulation works through multiple biological pathways simultaneously,” explains Dr. Michael Hamblin of Harvard Medical School, one of the leading researchers in the field. “When red or near-infrared light reaches the mitochondria, it nudges them to produce energy more efficiently and boost production of healing anti-inflammatories.
It’s the depth of penetration that counts here. Red light (630-660 nm) is effective for superficial tissues, such as skin, connective tissue, and smaller joints of hands and feet. Near-infrared light (800-850 nm) penetrates deeper into muscles and joint capsules and is more appropriate for knees, hips and shoulders.
Red Light Therapy for Osteoarthritis: Where the Evidence Is Strongest
Of the two major arthritis types, OA has significantly more clinical support for PBM. The body of research is large enough now that multiple systematic reviews and meta-analyses have been conducted, and the picture that emerges is genuinely encouraging – with some important caveats.
A 2024 network meta-analysis of 13 randomized controlled trials involving 673 patients found that near-infrared light therapy delivered the largest pain reduction in knee osteoarthritis, with a SUCRA score of 86.90%. That’s a meaningful result in a well-designed analysis.
A systematic review published in Physical Therapy in 2024 confirmed that PBM reduces pain intensity and may improve disability scores in knee OA patients – though the authors emphasized that the certainty of evidence remains low to moderate and recommended it as an add-on to standard care rather than a replacement.
For osteoarthritis, a study by Alves et al. (2021) found that patients experienced approximately a 50% reduction in pain and meaningful improvements in grip strength after 12 sessions of PBM therapy.
The research is more compelling for knee OA than for hip OA – partly because knees are easier to target with devices and have been studied more extensively, and partly because the hip joint sits deeper and is harder to reach with current home devices.
Honest assessment: For osteoarthritis – particularly of the knee and hands – red light therapy has a reasonable evidence base as a complementary tool for pain and function. It’s not a cure, and results vary, but the risk profile is low and the potential upside is real enough to warrant serious consideration as part of a broader management plan.
Red Light Therapy for Rheumatoid Arthritis: A More Complicated Picture
Rheumatoid arthritis is where the evidence becomes more nuanced – and where you need to be careful about overstated claims.
The older literature was actually fairly optimistic. A review of 18 double-blind trials in chronic RA patients found significant improvement in both acute small joint inflammation and chronic pain, with roughly an 80% success rate in relieving pain. A separate study of 170 RA patients showed pain reduction of up to 90%. These numbers sound impressive, but many of these older studies had small sample sizes and methodological limitations.
More recently, a 2023 systematic review and meta-analysis published in PLOS ONE took a rigorous look at controlled trials specifically examining LLLT in adults with RA. The findings: PBM may offer short-term relief for pain and morning stiffness, but the effects are modest and the certainty of evidence is low.
What’s the likely explanation for the inconsistency? RA is driven by systemic immune dysregulation. Light therapy works locally, at the tissue level. It may reduce local inflammation and provide symptomatic relief around specific joints, but it doesn’t address the underlying autoimmune process that makes RA a whole-body disease.
“For patients with rheumatoid arthritis, I see red light therapy as a potential adjunct for managing localized joint discomfort, not a replacement for disease-modifying treatment,” says Dr. Jonathan Spages, a functional medicine specialist based in New Jersey. “It may help with morning stiffness and comfort between medication doses, but it needs to be part of a broader plan that addresses the immune component.”
Honest assessment: PBM may help RA patients manage day-to-day joint pain and stiffness as a complement to their existing treatment plan. It should not be positioned as an alternative to DMARDs or other disease-modifying therapies, and patients with RA should involve their rheumatologist in any decision to add it.
Does Red Light Therapy Help with Rheumatoid Arthritis Specifically?
People searching this question usually want to know whether it’s worth trying, not whether the evidence is publication-ready. Fair enough.
Here’s a practical way to think about it: the inflammation in RA-affected joints responds to the same anti-inflammatory mechanisms that PBM triggers. Studies consistently show reductions in TNF-α and IL-6 locally – the very cytokines responsible for the pain and swelling you feel in individual joints. So there’s a plausible and observed mechanism.
What light therapy can’t do is switch off the systemic immune response that keeps reigniting that local inflammation. It’s treating the symptom at the tissue level, not the cause at the immune level.
For someone whose RA is well-controlled on medication but who still has persistent localized joint discomfort, PBM is a reasonable low-risk addition. For someone in an active flare with poorly controlled disease, it’s unlikely to move the needle much on its own.
MOST POPULAR IN HEALTH
What Wavelengths and Protocols Actually Matter
Most of the research supporting red light therapy for arthritis uses wavelengths in the 630–905 nm range. Here’s how to think about it practically:
660 nm (red) – Works well for superficial tissue, small joints (fingers, wrists, toes), and surface inflammation. Good for hands affected by either OA or RA.
810–850 nm (near-infrared) – The workhorse wavelength for deeper joint structures. Penetrates muscle, joint capsules, and reaches structures like the knee meniscus and subchondral bone. This is what you want for knees, hips, and shoulders.
904–905 nm – Used primarily in clinical settings. The 2024 network meta-analysis found this wavelength delivered the largest pain reduction in knee OA (SUCRA 86.90%), though consumer devices at this wavelength are less common.
Most of the best red light therapy devices for arthritis combine both red and near-infrared wavelengths, which tend to outperform single-wavelength devices in clinical studies because they can target both superficial and deeper tissues simultaneously.
Practical protocol based on the research:
- Session duration: 10–20 minutes per joint area
- Frequency: 3–5 sessions per week – studies suggest this range produces the best cumulative outcomes
- Device distance: 6–12 inches from the skin for most panel-style devices
- Dose range: 20–40 J/cm² is most commonly cited for arthritis and deep tissue targets
- Timeline: Most clinical trials show meaningful changes at 4–8 weeks of consistent use; don’t judge it at two weeks
One important note on biphasic dosing: light therapy follows a “more is not always better” curve. Too little does nothing; the right amount helps; too much can blunt or even reverse the benefit. This is why protocol consistency matters more than simply maxing out session time.
Red Light Therapy for Dogs with Arthritis
Arthritis affects roughly 20% of adult dogs and up to 90% of senior dogs. The same degenerative joint process that breaks down cartilage in humans happens in dogs too, and the biological mechanisms through which PBM acts on joint tissue are largely shared across mammals.
Research published in the Journal of Veterinary Science and documented by the American Veterinary Medical Association confirms that red light therapy (often administered as cold laser therapy in clinical settings) can reduce discomfort, improve mobility, and support quality of life in dogs with osteoarthritis. A 2020 study specifically found that dogs receiving laser therapy showed less pain and improved quality of life compared to controls.
Veterinary studies generally show 70–80% of dogs showing meaningful improvement in mobility and comfort. Side effects are minimal – the therapy is non-invasive, painless, and drug-free, which is particularly appealing for pet owners who want to reduce their dog’s NSAID load.
What to look for in a device for dogs: the same wavelength principles apply – 660 nm for surface-level treatment, 810–850 nm for deeper joints like hips and elbows. Session times are typically shorter for dogs (5–10 minutes per area), and most vets recommend starting with in-clinic sessions to establish the protocol before transitioning to home use.
Always consult your veterinarian before starting red light therapy on your dog, particularly if your pet is on other medications or has an underlying health condition.
Who Should Be Cautious
Red light therapy has a strong safety profile and is considered non-invasive, non-thermal, and free of UV radiation. That said, certain people should check with their doctor before starting:
- Anyone taking photosensitizing medications (certain antibiotics, diuretics, some psychiatric medications)
- People with a history of skin cancer or light-sensitive skin conditions
- Those with active infections over the treatment area
- Pregnant women (limited research; caution advised over the abdomen)
- People with implanted electronic devices near the treatment area
For RA patients specifically: red light therapy is not a substitute for DMARDs or biologic therapy. Use it alongside your existing treatment plan, not instead of it.
Frequently Asked Questions
Does red light therapy really work for arthritis?
A:For osteoarthritis – particularly the knee and hands – yes, there’s a meaningful evidence base supporting its use for pain and function. For rheumatoid arthritis, the evidence supports modest short-term relief for localized joint symptoms, though it doesn’t address the underlying autoimmune process. Results depend heavily on consistent use, correct wavelengths, and realistic expectations.
How long does it take for red light therapy to work for arthritis?
A: Most clinical trials show measurable changes between 4 and 8 weeks of consistent use (3–5 sessions per week). Some people notice improvements in stiffness sooner – particularly in the morning – but giving it a full 6–8 week trial before judging results is the standard in the research.
Is red light therapy good for rheumatoid arthritis?
A: It can help manage localized joint pain and morning stiffness as a complement to existing RA treatment. It doesn’t treat the systemic immune dysfunction driving RA, so it shouldn’t replace disease-modifying medications. Talk to your rheumatologist before adding it to your routine.
What wavelength is best for arthritis?
A: For small, superficial joints (fingers, wrists), 660 nm red light is effective. For deeper joints (knees, hips, shoulders), near-infrared at 810–850 nm reaches further into tissue. Devices combining both wavelengths tend to produce the best results.
Can I use red light therapy on my dog for arthritis?
A: Yes – veterinary research supports its use for canine arthritis, with the majority of studies showing improved mobility and reduced discomfort. Consult your vet first to confirm the protocol is appropriate for your dog’s specific condition and any medications they’re taking.
Conclusion
Red light therapy isn’t a cure for arthritis – anyone telling you otherwise is overselling it. But dismissing it entirely would also be getting it wrong.
For osteoarthritis, particularly of the knee, the clinical evidence is solid enough to take seriously. Used consistently, at the right wavelengths and doses, it appears to reduce pain, improve function, and possibly slow structural progression – all without the side effects that come with long-term NSAID use or corticosteroids. That’s a meaningful proposition for the roughly 60 million Americans living with some form of arthritis.
For rheumatoid arthritis, the picture is more modest. It’s a reasonable add-on for managing localized symptoms, but it doesn’t touch the autoimmune mechanism at the core of the disease. Use it alongside your rheumatologist’s plan, not as a reason to skip it.
The research is still developing, protocols aren’t yet standardized, and device quality varies enormously. But the biology makes sense, the safety profile is excellent, and for many people with arthritis – human and canine alike – it’s worth a genuine trial.
